348 related articles for article (PubMed ID: 33800091)
21. Development of four ruthenium polypyridyl complexes as antitumor agents: Design, biological evaluation and mechanism investigation.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
J Inorg Biochem; 2020 Jul; 208():111104. PubMed ID: 32485635
[TBL] [Abstract][Full Text] [Related]
22. Ruthenium(II)/(III) DMSO-Based Complexes of 2-Aminophenyl Benzimidazole with In Vitro and In Vivo Anticancer Activity.
Elsayed SA; Harrypersad S; Sahyon HA; El-Magd MA; Walsby CJ
Molecules; 2020 Sep; 25(18):. PubMed ID: 32962014
[TBL] [Abstract][Full Text] [Related]
23. Protein-binding, cytotoxicity in vitro and cell cycle arrest of ruthenium(II) polypyridyl complexes.
Liu SH; Zhu JW; Xu HH; Wang Y; Liu YM; Liang JB; Zhang GQ; Cao DH; Lin YY; Wu Y; Guo QF
Spectrochim Acta A Mol Biomol Spectrosc; 2016 May; 161():77-82. PubMed ID: 26956530
[TBL] [Abstract][Full Text] [Related]
24. Heterobimetallic Ru(ii)/Fe(ii) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets.
Guedes APM; Mello-Andrade F; Pires WC; de Sousa MAM; da Silva PFF; de Camargo MS; Gemeiner H; Amauri MA; Gomes Cardoso C; de Melo Reis PR; Silveira-Lacerda EP; Batista AA
Metallomics; 2020 Apr; 12(4):547-561. PubMed ID: 32108850
[TBL] [Abstract][Full Text] [Related]
25. A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent.
Chen J; Tao Q; Wu J; Wang M; Su Z; Qian Y; Yu T; Wang Y; Xue X; Liu HK
J Inorg Biochem; 2020 Sep; 210():111132. PubMed ID: 32569884
[TBL] [Abstract][Full Text] [Related]
26. A nuclear permeable Ru(ii)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies.
Tian N; Feng Y; Sun W; Lu J; Lu S; Yao Y; Li C; Wang X; Zhou Q
Dalton Trans; 2019 May; 48(19):6492-6500. PubMed ID: 30994660
[TBL] [Abstract][Full Text] [Related]
27. Ruthenium(II) complexes: DNA-binding, cytotoxicity, apoptosis, cellular localization, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential and western blot analysis.
Li W; Jiang GB; Yao JH; Wang XZ; Wang J; Han BJ; Xie YY; Lin GJ; Huang HL; Liu YJ
J Photochem Photobiol B; 2014 Nov; 140():94-104. PubMed ID: 25108205
[TBL] [Abstract][Full Text] [Related]
28. Ursolic acid-piperazine-dithiocarbamate ruthenium(II) polypyridyl complexes induced necroptosis in MGC-803 cells.
Jiang H; Wei JH; Lin CY; Liang GB; He RJ; Huang RZ; Ma XL; Huang GB; Zhang Y
Metallomics; 2022 Oct; 14(10):. PubMed ID: 36149330
[TBL] [Abstract][Full Text] [Related]
29. Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.
Zhao Z; Luo Z; Wu Q; Zheng W; Feng Y; Chen T
Dalton Trans; 2014 Dec; 43(45):17017-28. PubMed ID: 25087850
[TBL] [Abstract][Full Text] [Related]
30. A novel ruthenium(II)-polypyridyl complex inhibits cell proliferation and induces cell apoptosis by impairing DNA damage repair.
Yang Q; Zhang Z; Mei W; Sun F
J Chemother; 2014 Aug; 26(4):235-42. PubMed ID: 24070188
[TBL] [Abstract][Full Text] [Related]
31. Anticancer activity and mechanism of bis-pyrimidine based dimetallic Ru(II)(η
Bhatti MZ; Ali A; Duong HQ; Chen J; Rahman FU
J Inorg Biochem; 2019 May; 194():52-64. PubMed ID: 30831390
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo antiproliferative activity on lung cancer of two acylhydrazone based zinc(II) complexes.
Chang Q; Xie Y; Lu X; Zong Z; Zhang E; Cao S; Liang L
Bioorg Chem; 2024 Jun; 147():107422. PubMed ID: 38705106
[TBL] [Abstract][Full Text] [Related]
33. Lysosome-targeted ruthenium(II) complexes induce both apoptosis and autophagy in HeLa cells.
Pan NL; Liao JX; Huang MY; Zhang YQ; Chen JX; Zhang ZW; Yang ZX; Long XE; Wu XT; Sun J
J Inorg Biochem; 2022 Apr; 229():111729. PubMed ID: 35066350
[TBL] [Abstract][Full Text] [Related]
34. Diorganotin (IV) complexes with 4-nitro-N-phthaloyl-glycine: Synthesis, characterization, antitumor activity and DNA-binding studies.
Yan C; Zhang J; Liang T; Li Q
Biomed Pharmacother; 2015 Apr; 71():119-27. PubMed ID: 25960226
[TBL] [Abstract][Full Text] [Related]
35. Targeting RAS-RAF pathway significantly improves antitumor activity of Rigosertib-derived platinum(IV) complexes and overcomes cisplatin resistance.
Liu Z; Wang M; Wang H; Fang L; Gou S
Eur J Med Chem; 2020 May; 194():112269. PubMed ID: 32248002
[TBL] [Abstract][Full Text] [Related]
36. Ruthenium(II) polypyridyl complexes: cellular uptake, cell image and apoptosis of HeLa cancer cells induced by double targets.
Yu Q; Liu Y; Xu L; Zheng C; Le F; Qin X; Liu Y; Liu J
Eur J Med Chem; 2014 Jul; 82():82-95. PubMed ID: 24878637
[TBL] [Abstract][Full Text] [Related]
37. In vitro cytotoxicity, cellular uptake, reactive oxygen species and cell cycle arrest studies of novel ruthenium(II) polypyridyl complexes towards A549 lung cancer cell line.
Qasim Warraich M; Ghion A; Perdisatt L; O'Neill L; Casey A; O'Connor C
Drug Chem Toxicol; 2021 May; 44(3):319-329. PubMed ID: 30991856
[TBL] [Abstract][Full Text] [Related]
38. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system.
Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127
[TBL] [Abstract][Full Text] [Related]
39. A Cytostatic Ruthenium(II)-Platinum(II) Bis(terpyridyl) Anticancer Complex That Blocks Entry into S Phase by Up-regulating p27(KIP1).
Ramu V; Gill MR; Jarman PJ; Turton D; Thomas JA; Das A; Smythe C
Chemistry; 2015 Jun; 21(25):9185-97. PubMed ID: 25950156
[TBL] [Abstract][Full Text] [Related]
40. Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity.
Čanović P; Simović AR; Radisavljević S; Bratsos I; Demitri N; Mitrović M; Zelen I; Bugarčić ŽD
J Biol Inorg Chem; 2017 Oct; 22(7):1007-1028. PubMed ID: 28695374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
